tiprankstipranks
Trending News
More News >
Xspray Pharma AB (SE:XSPRAY)
:XSPRAY
Sweden Market

Xspray Pharma AB (XSPRAY) Income Statement

Compare
1 Followers

Xspray Pharma AB Income Statement

Last quarter (Q1 2025), Xspray Pharma AB's total revenue was kr0.00, a decrease of -100.00% from the same quarter last year. In Q1, Xspray Pharma AB's net income was kr-42.29M. See Xspray Pharma AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profit
kr 0.00kr -9.19Mkr -9.53Mkr -8.87Mkr -1.41M
Operating Expenses
kr 287.04Mkr 181.73Mkr 131.38Mkr 96.95Mkr 53.65M
Depreciation and Amortization
kr 5.48Mkr 9.19Mkr 9.53Mkr 8.87Mkr 1.41M
EBITDA
kr -277.76Mkr -169.81Mkr -122.13Mkr -87.82Mkr -50.99M
Operating Income
kr -287.04Mkr -181.73Mkr -133.07Mkr -97.95Mkr -53.46M
Other Income/Expenses
kr 1.37Mkr 2.05Mkr 1.40Mkr 1.25Mkr 1.05M
Pretax Income
kr -285.67Mkr -179.68Mkr -131.67Mkr -96.70Mkr -52.41M
Net Income
kr -285.52Mkr -179.67Mkr -130.27Mkr -96.70Mkr -52.30M
Per Share Metrics
Basic EPS
kr -8.62kr -6.76kr -6.13kr -4.98kr -3.01
Diluted EPS
kr -8.62kr -6.76kr -6.13kr -4.98kr -3.01
Weighted Average Shares Outstanding
33.12M 26.58M 21.26M 19.41M 17.37M
Weighted Average Shares Outstanding (Diluted)
33.14M 26.59M 21.26M 19.41M 17.37M
Currency in SEK

Xspray Pharma AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis